---
title: "Regulatory Update: Hong Kong"
description: Hong Kong regulatory update, February 2024
image: https://blog.arazygroup.com/hubfs/Hong_Kong.jpg
---

Open main menu Close main menu

- [Join The Regulatory Rockstar Movement](https://info.arazygroup.com/regulatory_rockstar_movement)

[Regulatory Update](https://blog.arazygroup.com/regulatory-affairs-advance/tag/regulatory-update)

# Regulatory Update: Hong Kong

[Arazy Group](https://blog.arazygroup.com/regulatory-affairs-advance/author/arazy-group)

[Share this blog post on Twitter](https://twitter.com/intent/tweet?text=I+found+this+interesting+blog+post&url=https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-hong-kong) [Share this blog post on Facebook](http://www.facebook.com/share.php?u=https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-hong-kong) [Share this blog post on LinkedIn](http://www.linkedin.com/shareArticle?mini=true&url=https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-hong-kong)

![](https://blog.arazygroup.com/hubfs/Hong_Kong.jpg)

##### Announcement on the Medical Device Administrative Management System Accepting Sales Approval from the National Medical Products Administration and the Korean Food and Drug Safety Agency

In a significant move towards fostering international collaboration and ensuring the highest standards of safety and performance, the Hong Kong Medical Device Division (MDD) has recently made a groundbreaking announcement regarding the acceptance of marketing approvals for medical devices and instruments.

Starting from January 1, 2024, the MDD will consistently recognize sales approvals from the National Medical Products Administration in Mainland China for medical devices adhering to the "Basic Principles of Safety and Performance" of the Medical Device Administrative System (MDACS) (Technical Reference: TR-004).

Furthermore, as of January 1, 2024, the Medical Instrument Division will routinely acknowledge existing sales approvals from the Korean Food and Drug Safety Agency (MFDS) to support compliance with the MDACS "Basic Principles of Safety and Performance" (Technical Reference: TR-004) for medical instruments.

For the full resource, available in Chinese and English, please visit[here](https://www.mdd.gov.hk/tc/whats-new/mdacs-activities/index-id-2317.html).

[Follow us on Facebook](https://www.facebook.com/Arazygroup/) [Follow us on LinkedIn](https://www.linkedin.com/company/arazy-group) [Follow us on Instagram](https://www.instagram.com/arazy_group/)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Arazy Group",
    "url" : "https://blog.arazygroup.com/regulatory-affairs-advance/author/arazy-group"
  },
  "dateModified" : "2024-06-21T18:41:39.166Z",
  "datePublished" : "2024-02-27T18:18:43.000Z",
  "headline" : "Regulatory Update: Hong Kong",
  "image" : [ "https://blog.arazygroup.com/hubfs/Hong_Kong.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-hong-kong",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://blog.arazygroup.com/hubfs/Arazy%20Group%20Logos%201.png"
    },
    "name" : "Arazy Group Consultants Inc."
  }
}
```